Medpace Holdings (MEDP) Long-Term Deferred Tax (2015 - 2026)

Medpace Holdings has reported Long-Term Deferred Tax for 12 years, with the latest figure at $3.2 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Deferred Tax fell 96.77% year-over-year to $3.2 million; the trailing twelve-month figure through Mar 2026 stood at $3.2 million (down 96.77% YoY), and the FY2025 full-year result was $19.2 million, down 80.85% from the prior year.
• Long-Term Deferred Tax for Q1 2026 stood at $3.2 million, down from $19.2 million in the prior quarter.
• The five-year high for Long-Term Deferred Tax was $100.4 million in Q4 2024, with the low at $3.2 million in Q1 2026.
• Historically, Long-Term Deferred Tax has averaged $53.8 million across 5 years, with a median of $51.8 million in 2023.
• Annual changes were most pronounced in 2022 — Long-Term Deferred Tax surged 4796.48% — and 2026, when it sank 96.77%.
• Medpace Holdings' Long-Term Deferred Tax stood at $48.1 million in 2022, then jumped by 54.81% to $74.4 million in 2023, then surged by 34.83% to $100.4 million in 2024, then tumbled by 80.85% to $19.2 million in 2025, then sank by 83.25% to $3.2 million in 2026.
• The last three Long-Term Deferred Tax figures came in at $3.2 million (Q1 2026), $19.2 million (Q4 2025), and $37.2 million (Q3 2025), per Business Quant data.